We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$489M
AUM Growth
+$8.91M
Cap. Flow
+$14.9M
Cap. Flow %
3.04%
Top 10 Hldgs %
42.69%
Holding
409
New
33
Increased
174
Reduced
80
Closed
38

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 5.6%
2 Financials 5.21%
3 Healthcare 4.88%
4 Industrials 4.48%
5 Technology 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
201
Pfizer
PFE
$153B
$115K 0.02%
3,626
+227
+7% +$7.4K
HQL
202
abrdn Life Sciences Investors
HQL
$627M
$113K 0.02%
4,000
+2,000
+100% +$55.4K
SYY icon
203
Sysco
SYY
$40.3B
$112K 0.02%
3,111
FXI icon
204
iShares China Large-Cap ETF
FXI
$4.31B
$112K 0.02%
2,425
+100
+4% +$4.95K
GWR
205
DELISTED
Genesee & Wyoming Inc.
GWR
$109K 0.02%
1,425
+30
+2% +$2.64K
EPI icon
206
WisdomTree India Earnings Fund ETF
EPI
$2.06B
$108K 0.02%
4,965
+1,015
+26% +$22.3K
AGU
207
DELISTED
Agrium
AGU
$107K 0.02%
1,008
MVT
208
DELISTED
BlackRock MuniVest Fund II
MVT
$106K 0.02%
7,150
+2,500
+54% +$39K
UNP icon
209
Union Pacific
UNP
$174B
$105K 0.02%
1,102
-4,496
-80% -$469K
AMZN icon
210
Amazon
AMZN
$2.96T
$105K 0.02%
4,840
AXP icon
211
American Express
AXP
$230B
$104K 0.02%
1,338
-356
-21% -$28.2K
SLB icon
212
SLB Ltd
SLB
$75B
$100K 0.02%
1,161
-125
-10% -$11.3K
EVT icon
213
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.16B
$99K 0.02%
5,000
NVS icon
214
Novartis
NVS
$297B
$98.7K 0.02%
1,120
KIO
215
KKR Income Opportunities Fund
KIO
$457M
$98.3K 0.02%
6,240
+3,500
+128% +$56.9K
BIO icon
216
Bio-Rad Laboratories Class A
BIO
$9.42B
$97.1K 0.02%
645
YHOO
217
DELISTED
Yahoo Inc
YHOO
$96.3K 0.02%
2,450
GAB icon
218
Gabelli Equity Trust
GAB
$1.79B
$93.9K 0.02%
15,468
+5,156
+50% +$32.4K
UHT
219
Universal Health Realty Income Trust
UHT
$594M
$92.9K 0.02%
2,000
XLNX
220
DELISTED
Xilinx Inc
XLNX
$92.9K 0.02%
2,104
-228
-10% -$10.3K
AAL icon
221
American Airlines Group
AAL
$10.6B
$89.1K 0.02%
2,230
AVT icon
222
Avnet
AVT
$7.92B
$85K 0.02%
2,068
PM icon
223
Philip Morris
PM
$295B
$85K 0.02%
1,060
-203
-16% -$16.7K
AMP icon
224
Ameriprise Financial
AMP
$48.8B
$85K 0.02%
680
AGN
225
DELISTED
Allergan plc
AGN
$83.5K 0.02%
275

Similar funds

Capital Analysts LLC's Q2 2015 Portfolio in Review

As of Q2 2015, Capital Analysts LLC held 409 positions worth $489M, up 1.9% from $480M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Capital Analysts LLC deployed $14.9M of net new capital in Q2 2015, opening 33 new positions and adding to 174 existing holdings. Its largest new stake was iShares MBS ETF: 31,326 shares worth $3.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 5.6% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $8.24M trimmed.

  • Capital Analysts LLC's largest Q2 2015 buy was iShares MBS ETF: 31,326 shares worth $3.4M.
  • Capital Analysts LLC added most to iShares TIPS Bond ETF in Q2 2015, an estimated $4.55M increase.
  • Capital Analysts LLC's biggest Q2 2015 reduction was iShares Russell 3000 ETF, cutting an estimated $8.24M.
  • Capital Analysts LLC fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2015, selling an estimated $3.83M.
  • Capital Analysts LLC's ten largest holdings make up 43% of its $489M portfolio in Q2 2015.
  • Capital Analysts LLC opened 33 new positions and closed 38 in Q2 2015.
  • Capital Analysts LLC's portfolio value rose 1.9% quarter-over-quarter to $489M.

Based on Capital Analysts LLC's 13F filing for Q2 2015, filed 14 Aug 2015.